Back to search

Belgium· BE-AMP-SAM663340-00

Axitinib Accord 5 mg

A axitinib product containing axitinib, registered in Belgium by Accord Healthcare. The same ATC class is registered in 14 of our 19 countries.

ATC L01EK01

Checked against FAMHP / AFMPS (Belgium) on

Informational only — not a medical device.

SOURCE REGISTER · BEFAMHP / AFMPS (Belgium)normalisedAxitinib Accord 5 mgATCL01EK01REGISTER NO.BE-AMP-SAM663340-00PACKS LISTED2CHECKEDSeptember 26, 2026

Where it is registered

Axitinib is registered in 14 of 19 countries.

Countries holding a registration under ATC L01EK01 (axitinib), each read from that country’s own register.

  • This record: Belgium, from FAMHP / AFMPS (Belgium)
  • 8 of them publish a price we can compare per daily dose

Axitinib · ATC L01EK01

14 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Germany
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of axitinib costs, country by country.

Normalised to the WHO defined daily dose (10 mg), the median price runs from $2.64 in France to $89.71 in Switzerland — a ×34 gap.

  • 2 markets with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown

Axitinib · price per daily dose (10 mg)

USD · FX 28 Sept 2026

  • CH Switzerland$89.71
  • FR France$2.64
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

FAMHP / AFMPS (Belgium)
Active substance
Axitinib
Manufacturer
Accord Healthcare
Country
Belgium (BE)
ATC code
L01EK01
ATC class
Axitinib
Defined daily dose
10 mg, O
Reimbursed
Not published by this register
Source register
FAMHP / AFMPS (Belgium)
Last checked
September 26, 2026

Packs & prices · 2

  • be_apb
    7743230
  • be_apb
    4927141

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

205 interactions on record for axitinib.

Graded by severity as the source publishes them — 64 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Axitinib · interactions on record

205 records

  • 64 severe
  • 117 moderate
  • 24 minor

Most severe, free to view

  • LonafarnibA16AX20severe
  • BosentanC02KX01severe
  • ConivaptanC03XA02severe
  • MipomersenC10AX11severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Axitinib in 15 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All axitinib products

Authorised across Europe · EMA

The same active substance is authorised in 26 EEA countries. Names it is sold under:

  • Austria · Axitinib, Axitinib Sandoz
  • Bulgaria · Axitinib Sandoz, Акситиниб Тева
  • Cyprus · Axitinib Sandoz, Axitinib Stada
  • Germany · Axitinib Al, Axitinib Hexal
  • Denmark · Axitinib Stada, Axitinib Teva
  • Estonia · Axitinib Sandoz, Axitinib Stada
  • Spain · Axitinib Stada, Axitinib Teva
  • Finland · Axitinib Avansor, Axitinib Sandoz
  • France · Axitiinib Eg, Axitinib Biogaran
  • United Kingdom (Northern Ireland) · Axitinib Genus Pharmaceuticals, Axitinib Teva Uk
  • Greece · Axitinib Faran, Axitinib Sandoz
  • Croatia · Aksitinib Alpha-Medical, Aksitinib Teva
  • Hungary · Axitinib Onkogen, Axitinib Sandoz
  • Iceland · Axitinib Accord, Axitinib Stada
  • Italy · Axitinib Eg, Axitinib Sandoz
  • Liechtenstein · Axitinib Accord, Inlyta
  • Lithuania · Axitinib Sandoz, Axitinib Stada
  • Luxembourg · Axitinib Eg, Axitinib Synthon
  • Latvia · Axitinib Sandoz, Axitinib Stada
  • Malta · Axitinib Synthon
  • Netherlands · Axitinib Sandoz, Axitinib Stada
  • Norway · Axitinib Accord, Axitinib Sandoz
  • Portugal · Axitinib Teva
  • Romania · Axitinib Stada
  • Sweden · Axitinib Avansor, Axitinib Sandoz
  • Slovenia · Aksitinib Sandoz, Aksitinib Teva

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/a857373d-5a32-4b3b-955d-32e11d2687ec
GET /v1/drugs/a857373d-5a32-4b3b-955d-32e11d2687ec?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Film-coated tablet",
  "source": "afmps",
  "status": "AUTHORIZED",
  "name_en": "Axitinib Accord 5 mg",
  "name_fr": "Axitinib Accord 5 mg",
  "name_nl": "Axitinib Accord 5 mg",
  "amp_code": "SAM663340-00",
  "strengths": [
    "5.0000",
    "5.0000",
    "54.2000"
  ],
  "pack_count": 5,
  "substances": [
    "Axitinib",
    "Lactose",
    "Lactose Monohydrate"
  ],
  "medicine_type": "ALLOPATHIC",
  "atc_description": "Axitinib",
  "authorisation_numbers": [
    "EU/1/24/1847/013",
    "EU/1/24/1847/015",
    "EU/1/24/1847/012",
    "EU/1/24/1847/011",
    "EU/1/24/1847/014"
  ]
}

See everything about axitinib.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.